EUVIMEDEUVIMED entdecken
Open Access

Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203

Kelsey L Corrigan iD, Rebecca Paulus iD, Ann H Klopp iD, Lari B Wenzel iD, Anamaria R Yeung iD, J Spencer Thompson iD, Desiree E Doncals iD, Vijayananda Kundapur iD, Nancy H Wiggers, Dasarahally S Mohan, Sharad A Ghamande, Shannon N Westin iD und 8 weitere

JCO Oncology Advances · 2025-05 · (2)

DOI: 10.1200/oa-24-00088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Advances, 2025-05. Verfasst von Kelsey L Corrigan und 19 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas MD Anderson Cancer Center, Houston, TX. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE NRG-RTOG 1203 reported that intensity-modulated radiation therapy (IMRT) reduced patient-reported GI toxicities in patients with cervical/endometrial cancer receiving postoperative RT, compared with 3-dimensional conformal radiation therapy (3DRT). We conducted a secondary analysis of patient-reported sexual function (PR-SF) among treatment groups to identify factors associated with sexual dysfunction. METHODS AND MATERIALS Patients on NRG-RTOG 1203 were randomly assigned to 3DRT versus IMRT and completed Patient-Reported Outcomes (PRO)-Common Terminology Criteria for Adverse Events (CTCAE) and FACT-Cx surveys at baseline, week 5 of RT, and at 4-6 weeks, 1 year, and 3 years after RT. Patient responses to FACT-Cx sexual function questions were analyzed. The between-arm frequency and severity of responses and their comparison with PRO-CTCAE GI toxicity were tested using chi-square tests. A repeated-measures logistic regression model was used to determine the impact of clinical and treatment factors on PR-SF. RESULTS Two hundred thirty-six patients completed PR-SF questions; 125 (53%) received 3DRT and 111 (47%) IMRT. There were no significant differences in PR-SF between groups ( P > .05). After RT, responses to “I am afraid to have sex” and “I am interested in sex” significantly improved over time ( P = .007 and P = .03, respectively). At 1 year after RT, women with interference from abdominal pain were more bothered by odor from the vagina versus women with no interference of abdominal pain (5% v 0%, P = .006). Additionally, at 1 year after RT, women with no severity of abdominal pain or no interference from abdominal pain liked their body appearance more versus women with at least some abdominal pain or some interference from abdominal pain (34% v 13%, P = .003 and 32% v 6%, P = .001, respectively). CONCLUSION PR-SF was similar between treatment groups. After RT, fear of sex declined and interest in sex improved over time. Women with GI toxicity after RT completion are at risk for worse sexual function.

Autor:innen und Institutionen

  • University of Texas MD Anderson Cancer Center, Houston, TX.
  • NRG Oncology Statistics and Data Management Center, Philadelphia, PA.
  • American College of Radiology, Philadelphia, PA.
  • University of California-Irvine, Irvine, CA.
  • University of Florida, Gainesville, FL.
  • University of Oklahoma Health Sciences Center, Oklahoma City, OK.

ORCID-Profile: Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, Lari B Wenzel, Anamaria R Yeung, J Spencer Thompson, Desiree E Doncals, Vijayananda Kundapur, Shannon N Westin, Michael L Haas, David K Gaffney, Steven E Waggoner, Lisa A Kachnic

Förderung

  • NCI NIH HHS

Zitieren

APA

Corrigan, K. L., Paulus, R., Klopp, A. H., Wenzel, L. B., Yeung, A. R., Thompson, J. S., Doncals, D. E., Kundapur, V., Wiggers, N. H., Mohan, D. S., Ghamande, S. A., Westin, S. N., Schnarr, K. L., Haas, M. L., Gaffney, D. K., Waggoner, S. E., Vanderwall, P. J., Jastaniyah, N. T., Pugh, S. L., & Kachnic, L. A. (2025). Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203. JCO Oncology Advances. https://doi.org/10.1200/oa-24-00088

Vancouver

Corrigan KL, Paulus R, Klopp AH, Wenzel LB, Yeung AR, Thompson JS, et al. Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203. JCO Oncology Advances. 2025. doi:10.1200/oa-24-00088

BibTeX
@article{Corrigan2025,
  author = {Corrigan, Kelsey L and Paulus, Rebecca and Klopp, Ann H and Wenzel, Lari B and Yeung, Anamaria R and Thompson, J Spencer and Doncals, Desiree E and Kundapur, Vijayananda and Wiggers, Nancy H and Mohan, Dasarahally S and Ghamande, Sharad A and Westin, Shannon N and Schnarr, Kara L and Haas, Michael L and Gaffney, David K and Waggoner, Steven E and Vanderwall, Pamela J and Jastaniyah, Noha T and Pugh, Stephanie L and Kachnic, Lisa A},
  title = {Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203},
  journal = {JCO Oncology Advances},
  year = {2025},
  number = {2},
  doi = {10.1200/oa-24-00088}
}
Kostenlos starten →